Key result
Case report illustrates the diagnostic challenges of life-threatening neuroleptic malignant syndrome triggered by antipsychotic drugs.
Case Report (n=1)
Highlights the diagnostic challenges of Neuroleptic Malignant Syndrome, a life-threatening neurological disorder caused by adverse reactions to neuroleptic or antipsychotic drugs.
Summary Neuroleptic malignant syndrome is a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic drugs. It is characterized by central neurotransmitter imbalance. The syndrome is thought to be caused by Dopaminergic block. Pooled data suggests the incidence of NMS is between 0.2%-3.20%. The mortality rate is very high at 55%, but may be reduced significantly by early recognition and improved management. We present this case as an example of the difficulty in diagnosing NMS.
No takes yet. Share an insight, caveat, or question.
Muhammet Emin Erdem (2015) conducted a case report in Neuroleptic Malignant Syndrome (n=1). Neuroleptic or antipsychotic drugs was evaluated. A case of neuroleptic malignant syndrome is presented to illustrate the difficulty in diagnosing this life-threatening neurological disorder caused by adverse reactions to antipsychotic drugs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: